Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium.

Autor: Delforge M; Afdeling Hematologie, UZ Gasthuisberg, Leuven. michel.delforge@uzleuven.be, Michiels A, Doyen C, Kentos A, Van Droogenbroeck J, Offner F, Bries G, Demuynck H, Vekemans MC, Meuleman N, Mineur PO, Ravoet C, Depryck B, Van de Velde A, Pierre P, Wu KL, Schots R

Publikováno v: Acta clinica Belgica [Acta Clin Belg] 2011 Sep-Oct; Vol. 66 (5), pp. 371-5.